Pain
Conference Coverage
Nerve growth factor antibody cuts OA pain with low AEs
CHICAGO – First phase 3 results from an OA trial testing a nerve growth factor antibody, tanezumab.
Conference Coverage
Smaller assistant ports mean less prolapse repair pain
LAS VEGAS – Patients experience less right-sided pain after laparoscopic sacrocolpopexy when surgeons use an 8-mm...
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
Opinion
FDA approval of powerful opioid tinged with irony
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
Conference Coverage
Opioids negatively affect breathing during sleep
Long-term use of opioids, including methadone therapy, increases the risk of central sleep apnea, though adaptive servo ventilation can...
News
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
Feature
Palliative care update highlights role of nonspecialists
The latest guideline revision aims to establish a foundation for “gold-standard” palliative care.
Conference Coverage
TENS cuts fibromyalgia pain in large RCT
CHICAGO – Women with fibromyalgia who self-administered transcutaneous electrical nerve stimulation reported greater pain reduction than controls...
From the Journals
XR-naltrexone beats oral medication for opioid use disorder
After 6 months, 57% of patients in the XR-naltrexone group were retained in treatment, compared with 28% of the oral group.
Feature
Diagnosis is an ongoing concern in endometriosis
For some women, it takes a village … of physicians.
From the Journals
Short-term NSAIDs appear safe for high-risk patients
The findings challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients...